Search Results - "Barish, Charles" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy

A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy

by Rex, Douglas K., Bhandari, Raj, Desta, Taddese, DeMicco, Michael P., Schaeffer, Cynthia, Etzkorn, Kyle, Barish, Charles F., Pruitt, Ronald, Cash, Brooks D., Quirk, Daniel, Tiongco, Felix, Sullivan, Shelby, Bernstein, David
Published in Gastrointestinal endoscopy (01.09.2018)

Get full text

Journal Article

Safety and tolerability of plecanatide in patients with chronic idiopathic constipation: long-term evidence from an open-label study

Safety and tolerability of plecanatide in patients with chronic idiopathic constipation: long-term evidence from an open-label study

by Barish, Charles F, Griffin, Patrick
Published in Current medical research and opinion (03.04.2018)

Get more information

Journal Article

Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation

Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation

by Barish, Charles F, Drossman, Douglas, Johanson, John F, Ueno, Ryuji
Published in Digestive diseases and sciences (01.04.2010)

Get full text

Journal Article

Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

by Barish, Charles F, Crozier, Robert A, Griffin, Patrick H
Published in Current medical research and opinion (02.01.2019)

Get more information

Journal Article

Sa1103 Economic and Medical Resource Use (MRU) Burden of Iron Deficiency Anemia (IDA) in an Inflammatory Bowel Disease (IBD) Population in the United States (US)

Sa1103 Economic and Medical Resource Use (MRU) Burden of Iron Deficiency Anemia (IDA) in an Inflammatory Bowel Disease (IBD) Population in the United States (US)

by Knight, Tyler, D'Sylva, Lynell, Barish, Charles F
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2014)

Get full text

Journal Article

Mo2039 Economic and Medical Resource Use (MRU) Burden of Iron Deficiency Anemia (IDA) in a Bariatric Surgery Population in the United States (US)

Mo2039 Economic and Medical Resource Use (MRU) Burden of Iron Deficiency Anemia (IDA) in a Bariatric Surgery Population in the United States (US)

by Knight, Tyler, D'Sylva, Lynell, Barish, Charles F
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2014)

Get full text

Journal Article

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

by Goel, Gautam, King, Tim, Daveson, A James, Andrews, Jane M, Krishnarajah, Janakan, Krause, Richard, Brown, Gregor J E, Fogel, Ronald, Barish, Charles F, Epstein, Roger, Kinney, Timothy P, Miner, Jr, Philip B, Tye-Din, Jason A, Girardin, Adam, Taavela, Juha, Popp, Alina, Sidney, John, Mäki, Markku, Goldstein, Kaela E, Griffin, Patrick H, Wang, Suyue, Dzuris, John L, Williams, Leslie J, Sette, Alessandro, Xavier, Ramnik J, Sollid, Ludvig M, Jabri, Bana, Anderson, Robert P
Published in The lancet. Gastroenterology & hepatology (01.07.2017)

Get more information

Journal Article

Burden of Iron Deficiency Anemia in a Bariatric Surgery Population in the United States

Burden of Iron Deficiency Anemia in a Bariatric Surgery Population in the United States

by Knight, Tyler, D'Sylva, Lynell, Moore, Brad, Barish, Charles F
Published in Journal of managed care & specialty pharmacy (01.10.2015)

Get full text

Journal Article

Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab

Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab

by Sands, Bruce E., Kozarek, Richard, Spainhour, Jack, Barish, Charles F., Becker, Scott, Goldberg, Lawrence, Katz, Seymour, Goldblum, Ronald, Harrigan, Rena, Hilton, Deborah, Hanauer, Stephen B.
Published in Inflammatory bowel diseases (01.01.2007)

Get full text

Journal Article

Safety, Pharmacokinetics, and Efficacy of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase 2a Study of Patients With Chronic Abdominal Pain Associated With Crohn’s Disease

Safety, Pharmacokinetics, and Efficacy of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase 2a Study of Patients With Chronic Abdominal Pain Associated With Crohn’s Disease

by Yacyshyn, Bruce R, Hanauer, Stephen, Klassen, Preston, English, Brett A, Stauber, Kathe, Barish, Charles F, Gilder, Kye, Turner, Stewart, Higgins, Peter D R
Published in Crohn's & colitis 360 (01.01.2021)

Get full text

Journal Article

Tu1073 Evaluation of Ferumoxytol Treatment for Iron Deficiency Anemia in Patients With Gastrointestinal Disorders Who Have a History of Unsatisfactory Oral Iron Therapy: Results of a Phase III, Randomized, Placebo-Controlled Trial

Tu1073 Evaluation of Ferumoxytol Treatment for Iron Deficiency Anemia in Patients With Gastrointestinal Disorders Who Have a History of Unsatisfactory Oral Iron Therapy: Results of a Phase III, Randomized, Placebo-Controlled Trial

by Ford, David, Cohen, Mitchell, Strauss, William, Barish, Charles F, Bernard, Kristine, Li, Joe, Allen, Lee
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2013)

Get full text

Journal Article

Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials

Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials

by Morris, David, Koch, Todd A., Butcher, Angelia, Bregman, David B., Barish, Charles F.
Published in Anemia (01.01.2012)

Get full text

Journal Article

Nitroglycerin 0.4% ointment vs placebo in the treatment of pain resulting from chronic anal fissure: a randomized, double-blind, placebo-controlled study

Nitroglycerin 0.4% ointment vs placebo in the treatment of pain resulting from chronic anal fissure: a randomized, double-blind, placebo-controlled study

by Berry, Scott M, Barish, Charles F, Bhandari, Raj, Clark, Gemma, Collins, Gregory V, Howell, Julian, Pappas, John E, Riff, Dennis S, Safdi, Michael, Yellowlees, Ann
Published in BMC gastroenterology (01.07.2013)

Get full text

Journal Article

Sa1395 Nexvax2®, a Peptide-Based Antigen-Specific Immunotherapy, Administered Intra-Dermally Three-Times Over 15-Days attenuates Responsiveness to Immuno-Dominant Gluten Peptides in HLA-DQ2.5+ People With Celiac Disease (CeD)

Sa1395 Nexvax2®, a Peptide-Based Antigen-Specific Immunotherapy, Administered Intra-Dermally Three-Times Over 15-Days attenuates Responsiveness to Immuno-Dominant Gluten Peptides in HLA-DQ2.5+ People With Celiac Disease (CeD)

by Goel, Gautam, Andrews, Jane M, Krause, Richard, Fogel, Ron, Barish, Charles F, Daveson, A.J, Epstein, Roger, King, Tim, Kinney, Timothy, Krishnarajah, Janakan, Miner, Philip B, Tye-Din, Jason A, Girardin, Adam, Taavela, Juha, Popp, Alina, Maki, Markku, Goldstein, Kaela, Dzuris, John L, Williams, Leslie J, Xavier, Ramnik, Sollid, Ludvig M, Jabri, Bana, Anderson, Robert P
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2016)

Get full text

Journal Article

A phase 1/2A Trial of STA 5326, an oral interleukin‐12/23 inhibitor, in patients with active moderate to severe Crohn's disease

A phase 1/2A Trial of STA 5326, an oral interleukin‐12/23 inhibitor, in patients with active moderate to severe Crohn's disease

by Burakoff, Robert, Barish, Charles F., Riff, Dennis, Pruitt, Ronald, Chey, William Y., Farraye, Francis A., Shafran, Ira, Katz, Seymour, Krone, Charles L., Vander Vliet, Martha, Stevens, Christopher, Sherman, Matthew L., Jacobson, Eric, Bleday, Ronald
Published in Inflammatory bowel diseases (01.07.2006)

Get full text

Journal Article

Sa1396 A Single Intradermal (ID) Injection of Nexvax2®, a Peptide Composition With Dominant Epitopes for Gluten-Reactive CD4+ T Cells, Activates T Cells and Triggers Acute Gastrointestinal Symptoms in HLA-DQ2.5+ People With Celiac Disease (CeD)

Sa1396 A Single Intradermal (ID) Injection of Nexvax2®, a Peptide Composition With Dominant Epitopes for Gluten-Reactive CD4+ T Cells, Activates T Cells and Triggers Acute Gastrointestinal Symptoms in HLA-DQ2.5+ People With Celiac Disease (CeD)

by Goel, Gautam, Mayassi, Toufic, Qiao, Shuo-Wang, Ciszewski, Cezary, King, Tim, Daveson, A.J, Andrews, Jane M, Krishnarajah, Janakan, Krause, Richard, Brown, Gregor J, Fogel, Ron, Barish, Charles F, Epstein, Roger, Kinney, Timothy, Miner, Philip B, Tye-Din, Jason A, Girardin, Adam, Goldstein, Kaela, Dzuris, John L, Williams, Leslie J, Xavier, Ramnik, Sollid, Ludvig M, Jabri, Bana, Anderson, Robert P
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2016)

Get full text

Journal Article

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders

by Ford, David C, Dahl, Naomi V, Strauss, William E, Barish, Charles F, Hetzel, David J, Bernard, Kristine, Li, Zhu, Allen, Lee F
Published in Clinical and experimental gastroenterology (01.01.2016)

Get full text

Journal Article

Alicaforsen therapy in inflammatory bowel disease

Alicaforsen therapy in inflammatory bowel disease

by Barish, Charles F
Published in Expert opinion on biological therapy (01.10.2005)

Get more information

Journal Article

Comparison of preference and safety of powder and liquid lactulose in adult patients with chronic constipation

Comparison of preference and safety of powder and liquid lactulose in adult patients with chronic constipation

by Barish, Charles F, Voss, Bryan, Kaelin, Byron
Published in Clinical and experimental gastroenterology (01.01.2010)

Get full text

Journal Article

Su1192 - Safety, Tolerability, and Effectiveness of Plecanatide in Patients with Constipation-Predominant Irritable Bowel Syndrome: Long-Term Evidence from an Open-Label Study

Su1192 - Safety, Tolerability, and Effectiveness of Plecanatide in Patients with Constipation-Predominant Irritable Bowel Syndrome: Long-Term Evidence from an Open-Label Study

by Barish, Charles F., Crozier, Robert
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2018)

Get full text

Journal Article